SMO ClinPlus CO.,LTD. (SHE:301257)

SMO ClinPlus CO.,LTD. Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Revenue Revenue Growth	824.77	842.5	803.73	760.04	586.23	502.97
Revenue Growth	3.16%	4.82%	5.75%	29.65%	16.55%	50.01%
Gross Profit Gross Profit Growth	164.1	217.95	195.98	231.1	159.98	131.19
Operating Income Operating Income Growth	50.58	107.71	93.44	130.52	68.73	67.49
Net Income Net Income Growth	58.07	109.64	106.43	134.73	72.41	57.77
Earnings Per Share EPS Growth	0.70	1.38	1.35	1.71	1.02	0.98
EPS Growth	-48.04%	2.22%	-21.05%	67.14%	3.91%	63.09%

Revenue by Geography

Chart

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
China China Growth	842.5	802.81	757.18	582.41	502.97
Overseas Overseas Growth	-	0.92	2.86	3.82	-
Total Total Growth	842.5	803.73	760.04	586.23	502.97

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Cash & Investments Cash & Investments Growth	576.93	617.59	889.56	914.48	813.83	135.65
Total Debt Total Debt Growth	3.38	4.32	6.57	11.08	4.35	4.72
Net Cash (Debt) Net Cash Growth	573.55	613.27	883	903.39	809.48	130.93
Net Cash Growth	-34.13%	-30.55%	-2.26%	11.60%	518.23%	27.08%
Net Cash Per Share Net Cash Per Share Growth	6.88	7.72	11.20	11.47	11.44	2.24

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	13.31	35.69	-1.07	114.85	40.44	41.52
Capital Expenditures CapEx Growth	-10.46	-7.83	-9.22	-10.25	-7.95	-4.4
Free Cash Flow Free Cash Flow Growth	2.84	27.86	-10.29	104.6	32.48	37.11
Free Cash Flow Growth	-	-	-	222.01%	-12.47%	102.11%

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Gross Margin	19.90%	25.87%	24.38%	30.41%	27.29%	26.08%
Operating Margin	6.13%	12.78%	11.63%	17.17%	11.72%	13.42%
Pretax Margin	8.63%	15.18%	15.13%	21.19%	13.79%	13.30%
Profit Margin	7.04%	13.01%	13.24%	17.73%	12.35%	11.49%
FCF Margin	0.34%	3.31%	-1.28%	13.76%	5.54%	7.38%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 1, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023
Dividend Per Share Dividend Per Share Growth	0.148	0.148	0.250	0.180	0.083
Dividend Per Share Growth	-40.80%	-40.80%	38.89%	116.61%	-
Dividend Yield	0.29%	0.29%	0.93%	0.37%	0.23%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 1, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
PE Ratio	57.26	37.50	20.14	28.83	40.35	-
Forward PE	-	37.71	17.34	26.00	-	-
P/FCF Ratio	1107.38	147.57	-	37.13	89.95	-
PS Ratio	3.82	4.88	2.67	5.11	4.98	-

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 1, 2026

Data Sources Report a data error